Role in the assessment and monitoring of EGFR-TKIs-induced cardiotoxicity sST2 as a biomarker of inflammation, fibrosis, and myocardial stress in the diagnosis and prognosis of heart failure and myocardial infarction has been increasingly studied. This evidence concerns the gene EGFR and heart failure.